ABSTRACT
Percutaneous coronary intervention (PCI) for coronary artery chronic total occlusion (CTO) is an important treatment to be used in conjunction with non-CTO PCI, coronary artery bypass grafting, and optimal medical therapy to achieve complete revascularization in patients with coronary artery disease.
Footnotes
Drs. Khatri and Abdallah reported no financial interests or relationships that pose a potential conflict of interest with this article. Dr. Ellis reported research grant support from Abbott Vascular and consulting/advisory fees from Abbott Vascular, Boston Scientific, and Medtronic.
- Copyright © 2017 The Cleveland Clinic Foundation. All Rights Reserved.
- Jaikirshan Khatri, MD⇑
- Correspondence:
Jaikirshan Khatri, MD, Department of Cardiovascular Medicine, Heart and Vascular Institute, J3-5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; khatrij{at}ccf.org
- Mouin Abdallah, MD
- Stephen Ellis, MD
ABSTRACT
Percutaneous coronary intervention (PCI) for coronary artery chronic total occlusion (CTO) is an important treatment to be used in conjunction with non-CTO PCI, coronary artery bypass grafting, and optimal medical therapy to achieve complete revascularization in patients with coronary artery disease.
Footnotes
Drs. Khatri and Abdallah reported no financial interests or relationships that pose a potential conflict of interest with this article. Dr. Ellis reported research grant support from Abbott Vascular and consulting/advisory fees from Abbott Vascular, Boston Scientific, and Medtronic.
- Copyright © 2017 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.